These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 13717185)

  • 1. [Studies on the neutralizing activity of immune sera in relation to various types of influenzal and parainfluenzal Sendai viruses].
    IABROV AA
    Vopr Virusol; 1961; 6():181-5. PubMed ID: 13717185
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of the neutralizing activity of immune sera to various types of influenza virus and Sendai parainfluenza virus.
    YABROV AA
    Probl Virol; 1961; 6():198-202. PubMed ID: 14040350
    [No Abstract]   [Full Text] [Related]  

  • 3. A tissue culture color test for the titration of neutralizing antibodies against Sendai virus (parainfluenza 1).
    VERSTEEG J; WILTERDINK JB
    Antonie Van Leeuwenhoek; 1961; 27():299-304. PubMed ID: 13925568
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the effect of non-specific virus-neutralizing substances from animal sera on influenza viruses].
    PETROV IuK
    Vopr Virusol; 1960; 5():167-72. PubMed ID: 14432341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Types of blood adsorption caused by influenzal and parainfluenzal viruses: preliminary communication].
    BUKRINSKAIA AG
    Vopr Virusol; 1960; 5():156-60. PubMed ID: 13805829
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibodies against Sendai virus among the Dutch people].
    VERSTEEG J
    Ned Tijdschr Geneeskd; 1961 Dec; 105():2458-60. PubMed ID: 13925569
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemical investigations of influenza virus neutralizing protein fractions of sera from different animals.
    POLYAK RI; LUZYANINA TI; SMORODINTSEV AA
    Acta Virol; 1959; 3(Suppl)():61-70. PubMed ID: 13854381
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative effectiveness of carbon dioxide, Vibrio comma filtrate and potassium periodate methods of serum treatment in the elimination of non-specific influenza virus A2 hemagglutination inhibitors].
    GORBUNOVA AS; STAKHANOVA VM; LOZHKINA AN; OLLI VD
    Vopr Virusol; 1959; 4():750-3. PubMed ID: 13851137
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of human sera for antihaemagglutinins to influenza-like animal viruses.
    ZHDANOV VM; STAKHANOVA VM
    Acta Virol; 1960 May; 4():187-8. PubMed ID: 13855484
    [No Abstract]   [Full Text] [Related]  

  • 10. [Host antigens in the structure of influenza viruses].
    Fridman EA; Bokhnevich GM
    Tr Inst Im Pastera; 1976; 47():167-73. PubMed ID: 80046
    [No Abstract]   [Full Text] [Related]  

  • 11. [A method of production of complement fixation antigens and corresponding antisera from soluble and viral fractions of influenza viruses (F. Lee's and W. Henle's technic)].
    GORBUNOVA AS
    Vopr Virusol; 1959; 4(1):113-4. PubMed ID: 13659955
    [No Abstract]   [Full Text] [Related]  

  • 12. On the strain specificity of the antibody response in influenza A, as measured by complement fixation using purified antigens, and its relation to in ovo neutralizing antibodies.
    HOLTERMANN OA; PETERSEN KB
    Acta Pathol Microbiol Scand; 1960; 50():430-42. PubMed ID: 13715561
    [No Abstract]   [Full Text] [Related]  

  • 13. Freeze-dried virus antigen containing cells and FITC-conjugated immune sera for virus diagnostic purposes.
    Simon M; Koller M; Barb K; Takátsy Gy; Kiss I
    Dev Biol Stand; 1974; 27():209-13. PubMed ID: 4218992
    [No Abstract]   [Full Text] [Related]  

  • 14. [Biological characteristics of influenza B viruses isolated during influenza B epidemics in 1976-1977].
    Nekliudova LI; Gumennik AE; Fedorova IuB; Orlova NG; Denimbetova GA
    Vopr Virusol; 1978; (4):427-33. PubMed ID: 749340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of influenza A viruses by immunodiffusion test.
    Samadieh B; Bankowski RA
    Am J Vet Res; 1971 Mar; 32(3):479-84. PubMed ID: 4993793
    [No Abstract]   [Full Text] [Related]  

  • 16. Latent infection caused by Sendal parainfluenza virus in laboratory animals. I. Isolation of Sendai virus from the lungs of white mice during adaptation of A-2/59 influenza virus to mice.
    HO YD; GORBUNOVA AS
    Probl Virol; 1961; 6():514-21. PubMed ID: 14036255
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on several inhibitors against influenza viruses. 2. beta-Inhibitor, its biological and physicochemical properties with particular emphasis on the differences from alpha-inhibitor, immune serum and properdin.
    KONNO J
    Tohoku J Exp Med; 1958 Apr; 67(4):391-405. PubMed ID: 13581059
    [No Abstract]   [Full Text] [Related]  

  • 18. The antibody content of immune sera absorbed with influenza virus, as determined by different serological tests.
    TAKATSY G; HAMAR M
    Acta Microbiol Acad Sci Hung; 1956; 3(3):299-306. PubMed ID: 13326293
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antigenic mutability of influenza virus types A2, B and C in the People's Republic of Bulgaria during the period 1956-1967].
    Nikolova Z
    Vopr Virusol; 1969; 14(1):107-9. PubMed ID: 4978626
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
    Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
    Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.